Literature DB >> 26596831

MicroRNA-125b suppresses the epithelial-mesenchymal transition and cell invasion by targeting ITGA9 in melanoma.

Jie Zhang1, Sijia Na2, Caiyue Liu3, Shuting Pan2, Junying Cai4, Jiaxuan Qiu5.   

Abstract

Increasing evidence has shown that aberrant miRNAs contribute to the development and progression of human melanoma. Previous studies have shown that miR-125b functions as a suppressor in malignant melanoma. However, the molecular function and mechanism by which miR-125b influences melanoma growth and invasion are still unclear. In this study, we aimed to investigate the role of miR-125b in melanoma progression and metastasis. We found that miR-125b expression is significantly downregulated in primary melanoma, and an even greater downregulation was observed in metastatic invasion. Restored expression of miR-125b in melanoma suppressed cell proliferation and invasion both in vitro and in vivo. Furthermore, our findings demonstrate that upregulating miR-125b significantly inhibits malignant phenotypes by repressing the expression of integrin alpha9 (ITGA9). Finally, our data reveal that upregulated expression of ITGA9 in melanoma tissues is inversely associated with miR-125b levels. Together, our results demonstrate that upregulation of ITGA9 in response to the decrease in miR-125b in metastatic melanoma is responsible for melanoma tumor cell migration and invasion.

Entities:  

Keywords:  EMT; ITGA9; Invasion; Melanoma; miR-125b

Mesh:

Substances:

Year:  2015        PMID: 26596831     DOI: 10.1007/s13277-015-4409-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  30 in total

1.  Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.

Authors:  Shiv K Gupta; Nicholas E Vlahakis
Journal:  Cell Adh Migr       Date:  2010-04-08       Impact factor: 3.405

Review 2.  microRNA functions.

Authors:  Natascha Bushati; Stephen M Cohen
Journal:  Annu Rev Cell Dev Biol       Date:  2007       Impact factor: 13.827

3.  Corrigendum to "CD44 variant, but not standard CD44 isoforms, mediate disassembly of endothelial VE-cadherin junction on metastatic melanoma cells" [FEBS Lett. 588 (24) (2014) 4573-4582].

Authors:  Pu Zhang; Changliang Fu; Huiyuan Bai; Erqun Song; Cheng Dong; Yang Song
Journal:  FEBS Lett       Date:  2015-01-27       Impact factor: 4.124

4.  MLK3 promotes melanoma proliferation and invasion and is a target of microRNA-125b.

Authors:  J Zhang; L Lu; Y Xiong; W Qin; Y Zhang; Y Qian; H Jiang; W Liu
Journal:  Clin Exp Dermatol       Date:  2014-04       Impact factor: 3.470

5.  miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer.

Authors:  Yan Zhang; Li-Xu Yan; Qi-Nian Wu; Zi-Ming Du; Jing Chen; Ding-Zhun Liao; Ma-Yan Huang; Jing-Hui Hou; Qiu-Liang Wu; Mu-Sheng Zeng; Wen-Lin Huang; Yi-Xin Zeng; Jian-Yong Shao
Journal:  Cancer Res       Date:  2011-03-28       Impact factor: 12.701

6.  The role of miR-125b-mitochondria-caspase-3 pathway in doxorubicin resistance and therapy in human breast cancer.

Authors:  Xiaohong Xie; Yuanyuan Hu; Leilai Xu; Yongqing Fu; Jue Tu; Hong Zhao; Shuo Zhang; Ri Hong; Xidong Gu
Journal:  Tumour Biol       Date:  2015-04-17

7.  The integrin alpha9beta1 on hematopoietic stem and progenitor cells: involvement in cell adhesion, proliferation and differentiation.

Authors:  Thomas D Schreiber; Carolin Steinl; Mike Essl; Harald Abele; Konstanze Geiger; Claudia A Müller; Wilhelm K Aicher; Gerd Klein
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

8.  The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14.

Authors:  R C Lee; R L Feinbaum; V Ambros
Journal:  Cell       Date:  1993-12-03       Impact factor: 41.582

9.  MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression.

Authors:  M Kappelmann; S Kuphal; G Meister; L Vardimon; A-K Bosserhoff
Journal:  Oncogene       Date:  2012-07-16       Impact factor: 9.867

Review 10.  MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.

Authors:  Marilena V Iorio; Carlo M Croce
Journal:  EMBO Mol Med       Date:  2012-02-20       Impact factor: 12.137

View more
  21 in total

Review 1.  Pivotal MicroRNAs in Melanoma: A Mini-Review.

Authors:  Zhenjun Deng; Jingang Hao; Dongyun Lei; Yongjing He; Lechun Lu; Li He
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

2.  Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathway.

Authors:  Xiangjun Chen; Hao Dong; Sha Liu; Li Yu; Dexiong Yan; Xingwei Yao; Weijing Sun; Dezhi Han; Guozhen Gao
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

3.  Population structure and genetic diversity in yellow catfish (Pelteobagrus fulvidraco) assessed with microsatellites.

Authors:  Wenjie Guo; Chengtao Guo; Yuhong Wang; Weihua Hu; Jie Mei
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

4.  Reduction in miRNA-125b-5p levels is associated with obstructive renal injury.

Authors:  Silu Wang; Lianfeng Wu; Linyong Du; Hong Lu; Bicheng Chen; Yongheng Bai
Journal:  Biomed Rep       Date:  2017-03-17

5.  Intratumoral interferon-gamma increases chemokine production but fails to increase T cell infiltration of human melanoma metastases.

Authors:  Ileana S Mauldin; Nolan A Wages; Anne M Stowman; Ena Wang; Mark E Smolkin; Walter C Olson; Donna H Deacon; Kelly T Smith; Nadedja V Galeassi; Kimberly A Chianese-Bullock; Lynn T Dengel; Francesco M Marincola; Gina R Petroni; David W Mullins; Craig L Slingluff
Journal:  Cancer Immunol Immunother       Date:  2016-08-13       Impact factor: 6.968

Review 6.  Micro RNAs Promoting Growth and Metastasis in Preclinical In Vivo Models of Subcutaneous Melanoma.

Authors:  Ulrich H Weidle; Simon AuslÄnder; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Nov-Dec       Impact factor: 4.069

Review 7.  Animal Models to Study MicroRNA Function.

Authors:  Arpita S Pal; Andrea L Kasinski
Journal:  Adv Cancer Res       Date:  2017-08-08       Impact factor: 6.242

Review 8.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

9.  Genetics and epigenetics of melanoma.

Authors:  Xiao-Ying Zhang; Pei-Ying Zhang
Journal:  Oncol Lett       Date:  2016-09-05       Impact factor: 2.967

10.  The Phosphorylation and Distribution of Cortactin Downstream of Integrin α9β1 Affects Cancer Cell Behaviour.

Authors:  Anette M Høye; John R Couchman; Ulla M Wewer; Atsuko Yoneda
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.